A new study has just been published in the journal of Diabetes (July 2012) illustrating the dramatic effects on mice when HBOT was applied. The study follows autoimmune diabetes development in non-obese diabetic mice. The results co-inside with other studies showing benefit for autoimmune diabetes. We now need to look at early intervention for children who are in the midst of developing Type 1 diabetes, and also for those that are at higher risk <view study> Read Less

Many private hyperbaric facilities are are providing HBOT for those inflicted with IBD, most commonly Crohn’s disease and Ulcerative Colitis. This new study demonstrates the usefulness of hyperbaric oxygen therapy for these conditions by showing the lowering of inflammatory markers and oxidative stress, alongside the improved clinical outcomes <view study> Read Less

Hyperbaric oxygen therapy (HBOT) has been used for treatments of many neurological conditions, and many patients have benefited from this procedure. Recently, a new study titled “hyperoxia preconditioning: the next frontier in neurology?” has expanded on recent literature showing that hyperbaric oxygen can condition the brain. With this latest information, it would make common sense for those wishing to PREVENT the effects of more common neurological conditions like stroke, Alzheimer disease, etc. to have a full course of HBOT. <view study> Read Less

Though hyperbaric oxygen therapy is not an FDA-approved treatment for autism, there are progressively, and exponentially, more autistic families that are seeking out hyperbaric therapy for their children, and some claim amazing benefits. The purpose of this review was to analyze the data and studies and try to help shed more light as to some of the key mechanisms of actions <view study> Read Less

Hyperbaric oxygen therapy is widely used for a variety of diabetes-induced conditions, particularly, but not limited, to wound healing. Its effects on diabetes-induced cataracts is still unclear. A study published in late 2001 in the Journal of Diabetes has given some new insights. They used lower pressures (1.25 ATA) and found that this dosage was able to delay both the development and the progression of diabetes-induced cataracts. <view study> Read Less